Top genetic analysis companies with Prof. Roberto Grobman
Genomic variants report services by Roberto Grobman today: Who we are? When we observed the incredible growth of scientific research after the completion of the genome project in 2003. Doctors and other health professionals were unable to update themselves with the millions of articles, results and conclusions published annually. Therefore, this information needed to be catalogued, filtered and transformed in some way to serve as a tool for health professionals. Our solution shows patients with a superior high accuracy rate what is written in their DNA, providing an excellent tool to understand what can happen and to act immediately to live longer and healthier. FullDNA provides an AI based customizable genetics prediction premium health tech platform to empower the capability of health professionals and institutions. FullDNA analyzes results from DNA sequencing Big Data using AI and complex algorithms to compares it with our own valuable extracted Database (updated daily) of more than 5,000 diseases and medical conditions, resulting in output of analysis & recommendation reports in various fields of medicine. Discover additional information at Roberto Grobman CTO.
How will hospitals and doctors be able to use our DNA data? Imagine if our doctor and the hospitals treating us had additional insights into our individual response to medication. The opportunity to enhance our treatment plan could be really beneficial. In practice, right now, that could happen with a doctor or patient sharing their pharmacogenomics report. In order to be effective at scale we would need to see pharmacogenomics results and reports stored in a patient’s electronic health record.
DNA report providers from Prof. Roberto Grobman today: Direct-to-consumer genetic testing provides only partial information about your health. Other genetic and environmental factors, lifestyle choices, and family medical history also affect the likelihood of developing many disorders. These factors would be discussed during a consultation with a doctor or genetic counselor, but in many cases they are not addressed when using at-home genetic tests. For example, vitamin B-related DNA tests. We help people understand its role in maintaining a healthy nervous system and being able to fight infection, and, if you are prone to having a lower deficiency in this area, here are the things you can do to improve it — in this case, food and nutrition.
Prenatal testing. For people planning pregnancy or who are already pregnant, genetic testing is available to check for an extensive number of conditions, such as cystic fibrosis and Down syndrome. Cancer. A number of genes are known to increase the risk of certain cancers. Testing may be especially important for people with a family history of these cancers. Perhaps the most well-known are BRCA mutations, which increase the risk of breast, ovarian, and several other types of cancer. People who don’t know their family’s medical history. For example, a person who is adopted and has no information about family medical problems may learn they are at increased risk of a preventable disease, such as heart disease or colon cancer.
Within DNA testing, it is also important to know: is a given gene one that is modifiable? Do we know that with easily actioned lifestyle or environmental changes, someone can make a difference to a given factor? As such it means a lot to us to have the right kind of science and governance behind it. For example, we have a robust scientific advisory board that conducts the evidence inclusion protocol. This includes consensus of multiple peer-reviewed research studies so we know that an outcome is reliable. It’s really important to understand that.
Our studies identified the relationship between Coronavirus and Genetics. We performed genetic analysis with more than 300 coronavirus patients in Brazil. We divided into 3 groups. A group of patients in the ICU in serious condition. A group with patients in the hospital but in a moderate state and a group with patients at home, with mild manifestation of the disease. We have a tool capable of predicting which individuals are at greater or lesser risk for the pandemic, and regarding vaccine risks. Read additional info on Prof. Roberto Grobman.
